FeesSafety
Pluang+

Tariffs raise investment costs and consumer prices, warns Canada's US ambassador.

Market News
11 Nov 2026, 22:02 WIB
CNBC
View Source
Bearish
Tariffs raise investment costs and consumer prices, warns Canada's US ambassador.

Canada's ambassador to the U.S., Mark Wiseman, warned that President Trump's tariffs are increasing investment costs and discouraging business expansion. Research from the New York Fed shows that about 90% of tariff costs are passed to U.S. importers, with consumer prices expected to rise further in 2027. The tariff dispute between the U.S. and Canada, including duties on steel and automobiles, continues amid ongoing negotiations. Canadian officials urge removing tariffs to restore free trade and provide certainty for long-term investments, while Democrats plan to challenge the tariffs in Congress next year.

Canada's ambassador warning on tariffs and investment costs is the story subject, with Pluang's Industrials sector market data as context for readers. As of Nov 12, 2026 03:21 WIB, out of 135 priced US Industrials stocks on Pluang, 107 rose and 28 fell. Notable movers include MasTec Inc (MTZ) at USD 188.25 with a 1-day change of +4.10%, DHT Holdings Inc. (DHT) at USD 21.62 up +3.92%, and C.H. Robinson Worldwide, Inc. (CHRW) at USD 134.02 up +3.90%.

More News

Global beverage market to reach $2.78T by 2032, driven by nonalcoholic drinks and convenience trends.

Global beverage market to reach $2.78T by 2032, driven by nonalcoholic drinks and convenience trends.

The global beverage market is projected to grow from $2.03 trillion in 2026 to $2.78 trillion by 2032, at a CAGR of 5.35%. Growth is fueled by rising demand for nonalcoholic and functional beverages, convenience packaging, and premium products for sp...

Market News
Bullish
1 hour ago
Over 200 GLP-1 and incretin therapies in development are reshaping diabetes and obesity treatment landscapes.

Over 200 GLP-1 and incretin therapies in development are reshaping diabetes and obesity treatment landscapes.

DelveInsight's 2026 report reveals more than 200 GLP-1 receptor agonists and incretin-based therapies are in development by over 180 companies, targeting conditions like type 2 diabetes, obesity, and related metabolic disorders. Key players such as E...

Bullish
2 hours ago
Across Protocol warns users to avoid app amid possible security breach causing crypto losses

Across Protocol warns users to avoid app amid possible security breach causing crypto losses

Across Protocol has advised users to avoid its app and refrain from connecting wallets or signing transactions due to a potential security incident involving its domain. Users have reported significant losses, including $9,000 in USDC and over 7,000 ...

Market News
Bearish
5 hours ago
XRP addresses holding 10,000+ tokens rose 5.15% despite a 30% price drop in 7 weeks

XRP addresses holding 10,000+ tokens rose 5.15% despite a 30% price drop in 7 weeks

The number of XRP addresses holding at least 10,000 tokens increased by 16,815 over nine months, reaching about 343,500 addresses, a 5.15% rise, even as XRP's price fell approximately 30% in seven weeks. Addresses holding one million or more XRP hit ...

Technical Signals
Neutral
5 hours ago
Nvidia remains a strong Buy with 130% upside despite CEO probe and recent share drop.

Nvidia remains a strong Buy with 130% upside despite CEO probe and recent share drop.

Nvidia Corporation continues to be a compelling Buy despite recent share price declines and an ongoing investigation involving its CEO. The demand for Nvidia's chips remains strong, fueled by capital expenditure growth from hyperscalers and robust cl...

Analyst Insights
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App